Mylan Pharmaceuticals Private Limited (a subsidiary of Mylan N.V.) today announced the launch of Velpatasvir 100 mg/Sofosbuvir 400 mg Tablets under the brand name MyHep All in India.
The Medicines Patent Pool (MPP) has extended its licensing agreement with Bristol-Myers Squibb (BMS) to further increase access to atazanavir.
bioLytical Laboratories has announced that its INSTI HIV Self Test has been designated by the Global Fund as eligible for procurement by purchasing entities entitled to access Global Fund and UNITAID resources.
Roche received FDA approval for fourth-generation HIV combination antigen-antibody assay which allows detection of infection with high sensitivity and specificity.
With the increasing temperature, the health facilities in the capital city are seeing an increasing number of people coming with complaints of influenza, diarrhoea, common cold and allergies among other infections.
Comparatively low dose of snake antivenom is proved to be effective in Nepal, according to new research report.
Various significant improvement measures were taken in health sector in the year 2073 BS (2016-17 AD).
District Public Health Office, Jhapa has launched a 10-day campaign at Malaria-hit Pathamari in Kachankawal rural municipality, Jhapa from Tuesday.
Doctors are beginning to get answers to the question that every parent whose child has had a traumatic brain injury (TBI) wants to know: What will my child be like 10 years from now?
A total of 120 new patients of leprosy have been found in Bardiya district, the District Public Health Office (DPHO) said.